Literature DB >> 28793372

Area under the curve during OGTT in first-degree relatives of diabetic patients as an efficient indicator of future risk of type 2 diabetes and prediabetes.

Awat Feizi1,2, Rokhsareh Meamar1, Mohammad Eslamian1, Masoud Amini1, Maryam Nasri3, Bijan Iraj1.   

Abstract

OBJECTIVE: To establish whether the area under the curve of an OGTT has a predictive role in identifying prediabetic and diabetic subjects among first-degree relatives (FDR) of patients with diabetes mellitus type 2 (DM). DESIGN, PATIENTS AND MEASUREMENTS: In a population-based cohort study, 766 FDR of diabetic patients with a normal glucose tolerance test (NGT) completed a 2-hour OGTT. They were followed up for 7 years and classified according to the American Diabetes Association criteria into: NGT, impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and DM. Relative risk (RR) and 95% confidence intervals (95%CI) were calculated based on logistic regression. Receiver operator characteristic (ROC) analysis along with AUC at different intervals and at time points during the OGTT was used to evaluate the risk of prediabetes and diabetes.
RESULTS: Twenty-three subjects (3%) developed type 2 DM, 118 (29.3%) IFG, 81 (11.5%) IGT and 544 (71%) subjects remained NGT. AUC and mean difference of glucose in all high-risk groups demonstrated significant differences in both intervals and time points when compared to the NGT group. The cut-off values during OGTT to predict prediabetes and diabetes was determined as blood glucose more than 7.2 and 7.8 mmol/L at 30 and 60 minutes, respectively. The time point 60 has the highest predictive role for the development of diabetes, alone, and improved the performance of a prediction model containing multiple important clinical risk factors.
CONCLUSION: The data suggest that the glycaemic response to an OGTT may predict the risk of development of diabetes in first-degree relatives of DM patients.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  diabetes mellitus; first-degree relatives; oral glucose tolerance test; pre-diabetes

Mesh:

Substances:

Year:  2017        PMID: 28793372     DOI: 10.1111/cen.13443

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

1.  Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model.

Authors:  Mary Courtney Moore; Marta S Smith; Larry L Swift; Anthony H Cincotta; Michael Ezrokhi; Nicholas Cominos; Yahong Zhang; Ben Farmer; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-27       Impact factor: 4.310

2.  Diabetic family history in young Japanese persons with normal glucose tolerance associates with k-means clustering of glucose response to oral glucose load, insulinogenic index and Matsuda index.

Authors:  Norimitsu Murai; Naoko Saito; Sayuri Nii; Yuto Nishikawa; Asami Suzuki; Eriko Kodama; Tatsuya Iida; Kentaro Mikura; Hideyuki Imai; Mai Hashizume; Yasuyoshi Kigawa; Rie Tadokoro; Chiho Sugisawa; Kei Endo; Toru Iizaka; Fumiko Otsuka; Shun Ishibashi; Shoichiro Nagasaka
Journal:  Metabol Open       Date:  2022-06-13

3.  Severity of the metabolic syndrome as a predictor of prediabetes and type 2 diabetes in first degree relatives of type 2 diabetic patients: A 15-year prospective cohort study.

Authors:  Rokhsareh Meamar; Masoud Amini; Ashraf Aminorroaya; Maryam Nasri; Majid Abyar; Awat Feizi
Journal:  World J Diabetes       Date:  2020-05-15

4.  circMAP3K4 regulates insulin resistance in trophoblast cells during gestational diabetes mellitus by modulating the miR-6795-5p/PTPN1 axis.

Authors:  Runyu Du; Na Wu; Yu Bai; Lei Tang; Ling Li
Journal:  J Transl Med       Date:  2022-04-21       Impact factor: 8.440

5.  Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.

Authors:  Bernd Richter; Bianca Hemmingsen; Maria-Inti Metzendorf; Yemisi Takwoingi
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.